Friday, March 12, 2010
"Concise industry news from the US pharmaceutical industry..."
Out from the shadows - Why the rapid rise of emerging markets will change the pharmaceutical world as we know it.
1 of 16
Previous |
Next
Executive Interviews
Real-time data for manufacturing
Craig Dobbs of Waters describes definitive technologies for PAT and QbD initiatives.
No Comments
Understanding the new prescribing influences
Tom Haskell and John Moran of IMS’ Innovation Lab discuss how to evaluate new factors driving prescribing decisions.
No Comments
Rise of biologics
Nitin Sood of Agilent Automation Solutions explains the expansion of automation trends in life sciences.
No Comments
Understanding emerging markets
Eurand's Andrew Thompson shares insights on preparing for success in emerging markets.
No Comments
Optimizing your laboratory assets
GE Healthcare’s Matt Sawtell looks at the tools pharmaceutical companies can use to ensure they maximize their R&D dollars.
No Comments
1 of 16
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.